Targeting hypoxia induced er stress response to prevent cancer progression

dc.contributor.guide	Elango, K
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Sandhya, Chipurupalli
dc.date.accessioned	2020-09-10T15:12:42Z
dc.date.available	2020-09-10T15:12:42Z
dc.date.awarded	24/07/2020
dc.date.completed	2020
dc.date.registered	2015
dc.description.abstract	available
dc.description.note	quotsummary p 71-72, References 73-84 p quot
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-84 p
dc.identifier.uri	http://hdl.handle.net/10603/298932
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	222
dc.rights	university
dc.source.university	University
dc.subject.keyword	Cancer, Hypoxia, ER-Phagy, ER-stress, FAM134B, STING, NRF2
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Targeting hypoxia induced er stress response to prevent cancer progression
dc.title.alternative
dc.type.degree	Ph.D.